Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus

As the patents for biologic originator drugs expire, biosimilars are emerging as cost-effective alternatives within healthcare systems. Addressing various challenges in the clinical management of inflammatory bowel disease (IBD) remains crucial. To shed light on physicians’ current knowledge, belief...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Amico, Ferdinando, Solitano, Virginia, Magro, Fernando, Olivera, Pablo A., Halfvarson, Jonas, Rubin, David, Dignass, Axel, Al Awadhi, Sameer, Kobayashi, Taku, Queiroz, Natália Sousa Freitas, Calvo, Marta, Kotze, Paulo Gustavo, Ghosh, Subrata, Peyrin-Biroulet, Laurent, Danese, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574001/
https://www.ncbi.nlm.nih.gov/pubmed/37834994
http://dx.doi.org/10.3390/jcm12196350

Ejemplares similares

Ejemplares similares